{{Rsnum
|rsid=36686
|Gene=B3GNT3
|Chromosome=19
|position=17811986
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.2534
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=B3GNT3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 43.4 | 1.8
| HCB | 20.9 | 56.0 | 23.1
| JPT | 34.2 | 45.9 | 19.8
| YRI | 83.6 | 15.8 | 0.7
| ASW | 75.4 | 22.8 | 1.8
| CHB | 20.9 | 56.0 | 23.1
| CHD | 26.6 | 46.8 | 26.6
| GIH | 52.5 | 36.6 | 10.9
| LWK | 89.0 | 11.0 | 0.0
| MEX | 62.1 | 31.0 | 6.9
| MKK | 86.5 | 13.5 | 0.0
| TSI | 62.4 | 30.7 | 6.9
| HapMapRevision=28
}}[[rs36686]], a SNP in the [[B3GNT3]] gene also known as H328R, is associated with reduced risk for developing [[Non-Hodgkin Lymphoma]] based on a study of 458 patients. The odds ratio is 0.74 (CI: 0.59-0.93, p<0.01). {{PMID|17827388|OA=1
}}

{{GET Evidence
|gene=B3GNT3
|aa_change=Arg328His
|aa_change_short=R328H
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs36686
|overall_frequency_n=8576
|overall_frequency_d=10758
|overall_frequency=0.797174
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=88
|n_articles=0
|n_articles_annotated=0
|nblosum100=1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}